Home > Boards > US OTC > Cannabis > Medicine Man Technologies Inc. (SHWZ)

Considering the amount of time it takes me

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Fallingknife75 Member Profile
Member Level 
Followed By 171
Posts 5,062
Boards Moderated 3
Alias Born 10/05/10
160x600 placeholder
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/2/2020 5:32:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2020 4:55:55 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/17/2020 6:01:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2020 7:46:24 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 6/8/2020 6:03:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/5/2020 4:30:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2020 6:06:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2020 4:30:36 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/14/2020 4:08:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/12/2020 11:03:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2020 5:15:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2020 5:27:36 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/30/2020 4:08:32 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/3/2020 6:09:49 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/28/2020 8:13:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2020 8:06:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2020 8:31:24 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/30/2019 2:17:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/16/2019 5:06:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/11/2019 4:01:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2019 2:12:30 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 4:10:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/12/2019 4:07:04 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/1/2019 9:02:51 AM
Fallingknife75 Member Level  Sunday, 10/20/19 11:43:22 AM
Re: 1990 post# 2951
Post # of 4957 
Considering the amount of time it takes me to research all the 8K's and build the data into my spreadsheets, I prefer not to just hand out the information; I will provide a short summary though.

Total price of all acquisitions announced = $245,787,759

Total Cash payments = $102,470,927

Total Shares to be issued = 33,190,073

Projected annual revenues from acquisitions = $215,626,136

There is a void in information relating to the Medpharm/Medicine Man acquisitions; I haven't found it yet anyway. I have assumed a $50m price tag based upon a 1.25x multiple of the low end $40m in estimated annual revenue. The Cash payments/shares to be issued information does not include this acquisition since I haven't found a breakdown on it yet; will update after numbers are announced.

Keep in mind that some of the cash payments will be made over time with several of the acquisitions having an upfront payment then 12 month terms on the rest. Using Starbuds as an example; of the total cash payment, $15,502,544 is upfront while $7,751,272 is payable over the 12 months following the acquisition.

The share issuance also has some variables as well. The big thing to keep in mind with the shares is that portions of the issuance (not all) will have trading restrictions built into them. Even though the Outstanding share count will rise quickly, the Float (what is actually trade-able) should not go up significantly until the restrictions are lifted (usually after 1 year holding period). The Float remaining low will keep the volatility high and increases the chance of a large run when the "Herd" figures out that MDCL is the best in the industry.

Hope this helps,

Buy-Hold-Retire before your old,

Knife






Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist